Dr.Lung 对比 Tyme Wear 的使用情况和统计数据
Lung Doctor is an application for users with abnormal lung function such as asthma and chronic obstructive pulmonary disease. Users can cooperate with Kangtai Medical's spirometer to test their lung function status, and to understand the test data and lung function parameter trends in detail, to facilitate patient self-monitoring and management and doctors to check the condition.
Our device has passed the CFDA certification and the European Union CE certification.
CFDA registration certificate number: 冀械注准 20172200014
CE No.G1 050972 0050 Rev.04 Report No.:BJ20090203
【Disclaimer】
Users should consult a doctor's advice before making any medical decisions using the App.
Health consultation answers are only used as health consultation suggestions for users' reference, but not as the basis for diagnosis, diagnosis and treatment, nor as any legally valid written certification. If the user uses this as the basis for diagnosis and treatment, any negative impact or even loss caused by it will be the responsibility of the questioner himself, and the platform will not be responsible.
【Jurisdiction Statement】
We control and operate this App in countries and regions such as China and the European Union. The hardware devices connected to the app are only licensed in China and EU countries.
We make no representations about the applicability of any material on this App for any other location. If you choose to access the App from other locations, you are responsible for compliance with applicable local laws.
- Apple 应用商店
- 免费
- 医疗
商店排名
- -
Tyme Wear is a new wearable technology that dials in your unique zones. Train smarter, not harder.
Our app integrates with Health App, to gather information that will improve your training sessions for the best result. Your Health data is not linked to your account.
You will need a Tyme Wear smart shirt in order to use this app.
- Apple 应用商店
- 免费
- 健康与健身
商店排名
- -
Dr.Lung与Tyme Wear排名比较
对比 Dr.Lung 与 Tyme Wear 在过去 28 天内的排名趋势
排名
没有可用的数据
Dr.Lung VS.
Tyme Wear
十二月 23, 2024